Can I read Regulation of pharmaceutical markets in Germany: improving efficiency and controlling expenditures? on EtoBox?

Regulation of pharmaceutical markets in Germany: improving efficiency and controlling expenditures? by Reinhard Busse; Jonas Schreyögg; Klaus-Dirk Henke is a Economics, Econometrics and Finance article available to read on EtoBox.

What is Regulation of pharmaceutical markets in Germany: improving efficiency and controlling expenditures? about?

Rising pharmaceutical expenditure has become a major concern for policy makers in Germany over recent years. Therefore, the pharmaceutical market has been increasingly targeted by different kinds of regulation, focussing on both the supply and the demand side, using price, volume and spending controls. Specific regulations include price reductions, reference pricing, pharmacy rebates for sickness funds, increasing co-payments, an 'autidem' substitution, parallel imports, a negative list, directives, and finally, spending caps for pharmaceutical expenditure per physicians' association. Although it is difficult to attribute certain effects to single measures, some measures like reference pricing and physician spending caps are more effective and long-lasting than others. In spite of being opposed by physicians, the spending caps applied between 1993 and 2001 have limited pharmaceutical expenditure for an entire decade. However, while some measures do effectively control expenditures, their effect on allocative efficiency may be detrimental.

Who reads Regulation of pharmaceutical markets in Germany: improving efficiency and controlling expenditures??

Author

Reinhard Busse; Jonas Schreyögg; Klaus-Dirk Henke

Publisher

John Wiley and Sons; Wiley (John Wiley & Sons); John Wiley & Sons Inc.; Wiley (ISSN 0749-6753)

Published

2005

Language

EN

Field

Economics, Econometrics and Finance (Social Sciences)